Patents by Inventor Thierry Franck

Thierry Franck has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9195000
    Abstract: An optical fiber has two or more core regions disposed within a common cladding region. Each of the core regions is configured to guide a respective light transmission comprising at least one optical mode along the length of the fiber. The cores are arranged within the common cladding region according to a core configuration that substantially prevents crosstalk between modes of neighboring cores in the fiber, in a deployment of the fiber in which cross-coupling between neighboring cores is affected by perturbations arising in the deployed fiber.
    Type: Grant
    Filed: October 12, 2011
    Date of Patent: November 24, 2015
    Assignee: OFS FITEL, LLC.
    Inventors: John M Fini, Thierry Franck Taunay, Man F Yan, Benyuan Zhu
  • Patent number: 8923678
    Abstract: A multicore optical fiber includes a plurality of core regions disposed within a common cladding region. Each of the plurality of core regions is configured, in combination with the common cladding region, to propagate light along a longitudinal axis of the fiber. At least two core regions are configured to inhibit resonant coupling of propagated light therebetween within a selected region of operation. At least one segment of the fiber includes a twist that is configured such that when the twisted segment is subjected to a bend having a selected radius, the twist creates a controlled change in the amount of crosstalk between the at least two core regions, compared with the amount of crosstalk between the at least two core regions when a bend having the selected radius is introduced into a non-twisted segment of the fiber.
    Type: Grant
    Filed: December 2, 2010
    Date of Patent: December 30, 2014
    Assignee: OFS Fitel, LLC
    Inventors: John Michael Fini, Thierry Franck Taunay, Man F. Yan, Benyuan Zhu
  • Publication number: 20130188949
    Abstract: An optical fiber has two or more core regions disposed within a common cladding region. Each of the core regions is configured to guide a respective light transmission comprising at least one optical mode along the length of the fiber. The cores are arranged within the common cladding region according to a core configuration that substantially prevents crosstalk between modes of neighboring cores in the fiber, in a deployment of the fiber in which cross-coupling between neighboring cores is affected by perturbations arising in the deployed fiber.
    Type: Application
    Filed: October 12, 2011
    Publication date: July 25, 2013
    Applicant: OFS Fitel, LLC
    Inventors: John M Fini, Thierry Franck Taunay, Man F Yan, Benyuan Zhu
  • Patent number: 8399208
    Abstract: The present invention is related to accurate detection methods for the measurement only of myeloperoxidase (MPO) levels or neutrophils, preferably equine neutrophils, in complex biological samples. The present invention is further related to ELISA and SIEFED assays for such detection. SIEFED detection sensitivity of active peroxidase activity was found to be enhanced by the addition of nitrite. Such MPO measurement finds its use in many applications such as the prediction, diagnosis and/or monitoring of pathologies correlated with neutrophil activation and/or destruction; the evaluation of drugs and/or immunomodulators; the assessment of immune responses, either natural and/or after treatment with immunomodulators and/or drugs; and the study of cells and their ability to fight microorganisms and/or to destroy them.
    Type: Grant
    Filed: February 7, 2005
    Date of Patent: March 19, 2013
    Assignee: Universite de Liege
    Inventors: Didier Serteyn, Ginette Dupont, Thierry Franck, Stéphane Kohnen
  • Publication number: 20110129190
    Abstract: A multicore optical fiber includes a plurality of core regions disposed within a common cladding region. Each of the plurality of core regions is configured, in combination with the common cladding region, to propagate light along a longitudinal axis of the fiber. At least two core regions are configured to inhibit resonant coupling of propagated light therebetween within a selected region of operation. At least one segment of the fiber includes a twist that is configured such that when the twisted segment is subjected to a bend having a selected radius, the twist creates a controlled change in the amount of crosstalk between the at least two core regions, compared with the amount of crosstalk between the at least two core regions when a bend having the selected radius is introduced into a non-twisted segment of the fiber.
    Type: Application
    Filed: December 2, 2010
    Publication date: June 2, 2011
    Applicant: OFS Fitel, LLC
    Inventors: John Michael Fini, Thierry Franck Taunay, Man F. Yan, Benyuan Zhu
  • Publication number: 20100196926
    Abstract: The present invention is related to a combined method and kit (or device) for the sequential measurement of the enzymatically active fraction and the total amount of an enzyme [(such as myeloperoxidase (MPO)] in a sample, and that find improved applications in veterinary and human health fields.
    Type: Application
    Filed: June 2, 2008
    Publication date: August 5, 2010
    Applicant: UNIVERSITE DE LIEGE
    Inventors: Didier Serteyn, Ginette Dupont, Thierry Franck, Stephane Kohnen
  • Publication number: 20080233600
    Abstract: The present invention is related to accurate detection methods for the measurement only of myelopexidase (MPO) levels or neutrophils, preferably equine neutrophils, in complex biological samples. The present invention is further related to ELISA and SIEFED assays for such detection. SIEFED detection sensitivity of active peroxidase activity was found to be enhanced by the addition of nitrite. Such MPO measurement finds its use in many applications such as the prediction, diagnosis and/or monitoring of pathologies correlated with neutrophil activation and/or destruction; the evaluation of drugs and/or immunomodulators; the assessment of immune responses, either natural and/or after treatment with immunomodulators and/or drugs; and the study of cells and their ability to fight microorganisms and/or to destroy them.
    Type: Application
    Filed: February 7, 2005
    Publication date: September 25, 2008
    Applicant: UNIVERSITE DE LIEGE
    Inventors: Didier Serteyn, Ginette DuPont, Thierry Franck, Stephane Kohnen